Synthesis of a PSMA-targeting ligand with an optimized linker for imaging and treatment of prostate cancer

被引：0
|
作者：
Murce, Erika [1 ]
Spaan, Evelien [1 ]
Seimbille, Yann [1 ]
机构：
[1] Erasmus MC, Rotterdam, Netherlands
来源：
NUCLEAR MEDICINE AND BIOLOGY | 2022年 / 108卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P-288
引用
收藏
页码：S206 / S207
页数：2
相关论文
共 50 条
  • [31] Novel Bispecific PSMA/GRPr Targeting Radioligands with Optimized Pharmacokinetics for Improved PET Imaging of Prostate Cancer
    Liolios, C.
    Schaefer, M.
    Haberkorn, U.
    Eder, M.
    Kopka, K.
    BIOCONJUGATE CHEMISTRY, 2016, 27 (03) : 737 - 751
  • [32] Synthesis and in vivo characterization of a heterobivalent radiotracer targeting PSMA and GRPR for prostate cancer imaging
    Bailly, Thibaud
    Prignon, Aurelie
    Morgat, Clement
    Goncalves, Victor
    Denat, Franck
    Valverde, Ibai
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S177 - S178
  • [33] Preclinical evaluation of PSMA-TO1-a PSMA-targeting ligand with increased circulating half-life
    Meyer, Catherine
    Stuparu, Andreea
    Lueckerath, Katharina
    Nyiranshuti, Lea
    Czernin, Johannes
    Dahlbom, Magnus
    Calais, Jeremie
    Slavik, Roger
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [34] Photoacoustic imaging with an acoustic lens detects prostate cancer cells labeled with PSMA-targeting near-infrared dye-conjugates
    Dogra, Vikram
    Chinni, Bhargava
    Singh, Shalini
    Schmitthenner, Hans
    Rao, Navalgund
    Krolewski, John J.
    Nastiuk, Kent L.
    JOURNAL OF BIOMEDICAL OPTICS, 2016, 21 (06)
  • [35] Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with 131I-MIP-1095
    Ali Afshar-Oromieh
    Uwe Haberkorn
    Christian Zechmann
    Thomas Armor
    Walter Mier
    Fabian Spohn
    Nils Debus
    Tim Holland-Letz
    John Babich
    Clemens Kratochwil
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 950 - 959
  • [36] Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with 131I-MIP-1095
    Afshar-Oromieh, Ali
    Haberkorn, Uwe
    Zechmann, Christian
    Armor, Thomas
    Mier, Walter
    Spohn, Fabian
    Debus, Nils
    Holland-Letz, Tim
    Babich, John
    Kratochwil, Clemens
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (06) : 950 - 959
  • [37] Synthesis and evaluation of a 68Ga-labeled PSMA-targeting tracer with a rigid linker to reduce kidney and salivary gland uptake
    Kuo, Hsiou-Ting
    Merkens, Helen
    Wang, Lei
    Benard, Francois
    Lin, Kuo-Shyan
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S152 - S153
  • [38] Towards Improving the Efficacy of PSMA-Targeting Radionuclide Therapy for Late-Stage Prostate Cancer—Combination Strategies
    Daria Arbuznikova
    Matthias Eder
    Anca-Ligia Grosu
    Philipp T. Meyer
    Christian Gratzke
    Constantinos Zamboglou
    Ann-Christin Eder
    Current Oncology Reports, 2023, 25 : 1363 - 1374
  • [39] Rational Linker Design to Accelerate Excretion and Reduce Background Uptake of Peptidomimetic PSMA-Targeting Hybrid Molecules
    Eder, Ann-Christin
    Schaefer, Martin
    Schmidt, Jana
    Bauder-Wuest, Ulrike
    Roscher, Mareike
    Leotta, Karin
    Haberkorn, Uwe
    Kopka, Klaus
    Eder, Matthias
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (10) : 1461 - 1467
  • [40] Evaluation of a Long-circulating PSMA-targeting Peptide in a Xenograft Model of Bone Metastatic Prostate Cancer.
    Lo, W.
    Huang, Y.
    Chen, M.
    Lu, A.
    Wang, S.
    Chen, L.
    Farn, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S442 - S442
12345